We are a London-based biotechnology company developing a novel therapeutic platform, known as Antigenic Immune Modulation (AIM), designed to cure, improve, halt or prevent autoimmune disease. Our lead drug candidate targets Type 1 Diabetes (T1D), with a pipeline that includes psoriasis, rheumatoid arthritis, and multiple sclerosis. We are committed to transforming the lives of those affected by autoimmune disease and delivering life-changing therapies.
| Website | http://www.phaim.co.uk |
| Employees | 8 (2 on RocketReach) |
| Founded | 2014 |
| Address | POBox 77323, London, England SW15 9JA, GB |
| Phone | +44 20 7351 7011 |
| Industry | Biotechnology |
| Keywords | Biotechnology, Type 1 Diabetes, Therapeutic Platform, Pharmaceutical Research, Drug Development, Novel Therapeutics, Immunology, Biopharma, Drug Discovery, Pharmaceutical, Clinical Trials, Life Sciences, Precision Medicine, Healthcare, Medicine, Health |
| Competitors | AstraZeneca, GSK, Pfizer, Merck Group, Sanofi, Novartis, Bristol Myers Squibb, Roche, AbbVie, Lilly India +45 more (view full list) |
Looking for a particular Phaim Pharma Ltd employee's phone or email?
Phaim Pharma Ltd Questions
Nara Daubeney is the CEO of Phaim Pharma Ltd.
2 people are employed at Phaim Pharma Ltd.
Phaim Pharma Ltd is based in London, England.
Top Phaim Pharma Ltd Employees
Related Companies
